http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009039362-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88d03191fca2dfdf8ace6494f19bf7e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fe7f72dce186e0eca6fa7c6bb30489d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0be89ffd9074c22707ba6ac24bdce38e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca463c8bf395773bd2ff53322c0094c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a4811388bbf38ea7283828ed78c4c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a4336dc13b777820384f90eaf85af5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c892aa115a2fbf99112d7b70f913ca7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc877eb9e2ccc618933696dfd1c58f1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c6ea0be7324c62ce5b003a4a6bcec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d05940675c93c799b09511b3dca3b71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f147dada46bc6be6384b72a94b106a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f20f3fd7aee8c4e4eaebb95d7cc545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba62a2438b708899c67e8054e09135b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d17902765fbf9b675bff9cec79e245e8
publicationDate 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009039362-A3
titleOfInvention Chiral synthesis of diazepinoquinolines
abstract The present invention relates to improved methods of resolution and recrystallization for synthesizing compounds of formulae (I-1) or (A) useful as 5HT2 agonists or partial agonists, including intermediates thereto.
priorityDate 2007-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1714963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4948897-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007020533-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006052768-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87550571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410538494

Total number of triples: 33.